Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte countsObbo W Bredewold, Hetty C. de Boer, Joris I. Rotmans et al.|Transplant Immunology|2024Cited by 2